Amin Dipti 4
4 · Lineage Cell Therapeutics, Inc. · Filed Jul 2, 2025
Insider Transaction Report
Form 4
Amin Dipti
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-07-01+75,000→ 75,000 totalExercise: $0.90Exp: 2035-07-01→ Common Shares (75,000 underlying)
Footnotes (1)
- [F1]Will vest and become exercisable on the earlier of July 1, 2026 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer.